SEOVF (Sernova Biotherapeutics) Total Current Liabilities: $7.96 Mil (As of Apr. 2026)


SEOVF Sernova Biotherapeutics Inc SEOVF
30 GF Score
Price $0.09
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Total Current Liabilities?

Sernova Biotherapeutics SEOVF -9.27% 30 Total Current Liabilities is $7.96 Mil as of Apr. 2026. GuruFocus rates SEOVF with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Sernova Biotherapeutics's total current liabilities for the quarter that ended in Apr. 2026 was $7.96

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Sernova Biotherapeutics Total Current Liabilities Related Terms

Sernova Biotherapeutics Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Total Current Liabilities Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 3.46 7.00 14.55 17.73

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.68 17.80 17.73 18.54 7.96
SEOVF
30GF Score
Sernova Biotherapeutics Inc SEOVF
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Sernova Biotherapeutics's Total Current Liabilities for the fiscal year that ended in Oct. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=6.119+2.667
+Other Current Liabilities+Current Deferred Liabilities
=0+8.942
=17.73

Sernova Biotherapeutics's Total Current Liabilities for the quarter that ended in Apr. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=6.341+1.617
+Other Current Liabilities+Current Deferred Liabilities
=-0.0010000000000003+0
=7.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of $7.96 Mil mean?
Sernova Biotherapeutics (SEOVF) has a Total Current Liabilities of $7.96 Mil as of Apr. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Sernova Biotherapeutics and its competitors.
Is Sernova Biotherapeutics' Total Current Liabilities too high?
Sernova Biotherapeutics' current Total Current Liabilities is $7.96 Mil. Overall, Sernova Biotherapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Total Current Liabilities compare to VRTX and REGN?
Sernova Biotherapeutics' Total Current Liabilities of $7.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Biotechnology company?
A good Total Current Liabilities depends on the Biotechnology industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Total Current Liabilities is $7.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (SEOVF) has a current Total Current Liabilities of $7.96 Mil. The current Total Current Liabilities is $7.96 Mil. Sernova Biotherapeutics' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Sernova Biotherapeutics (SEOVF), the current Total Current Liabilities is $7.96 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges PSH0:GermanySVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
30GF Score

Get the complete analysis for SEOVF

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price